Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.
暂无分享,去创建一个
C. Polman | M. Rep | H. Adèr | R. V. van Lier | B. V. van Oosten | M. Roos | B. W. Oosten | R. V. Lier | Martin H. G. Rep